Trial Profile
Pirfenidone, an Antifibrotic and Antiinflammatory Drug for Treatment of Patients With Cirrhosis Due to Hepatitis C Virus. Phase II/III Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- 04 Jul 2014 New trial record